These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1608407)

  • 1. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group.
    Caldwell-Brown D; Stern RS; Lin AN; Carter DM
    N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of systemic phenytoin in the treatment of junctional epidermolysis bullosa.
    Fine JD; Johnson L
    Arch Dermatol; 1988 Sep; 124(9):1402-6. PubMed ID: 3415285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
    Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
    Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: a feasibility trial.
    Lara-Corrales I; Parkin PC; Stephens D; Hamilton J; Koren G; Weinstein M; Sibbald RG; Pope E
    J Am Acad Dermatol; 2012 Feb; 66(2):264-70. PubMed ID: 22153787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis by electron microscopy of recessive dystrophic epidermolysis bullosa].
    Glorio RR; Solari A; Woscoff A
    Medicina (B Aires); 2000; 60(3):354-6. PubMed ID: 11050816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recessive dystrophic epidermolysis bullosa treated with phenytoin.
    Abahussein AA; al-Zayir AA; Mostafa WZ; Okoro AN
    Int J Dermatol; 1992 Oct; 31(10):730-2. PubMed ID: 1399206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. A comparison of short- and long-term treatment.
    Cooper TW; Bauer EA
    Arch Dermatol; 1984 Apr; 120(4):490-5. PubMed ID: 6703753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermolytic (dystrophic) epidermolysis bullosa inversa.
    Pearson RW; Paller AS
    Arch Dermatol; 1988 Apr; 124(4):544-7. PubMed ID: 3355197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase.
    Bauer EA; Cooper TW; Tucker DR; Esterly NB
    N Engl J Med; 1980 Oct; 303(14):776-81. PubMed ID: 6251365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Sporadic" dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?
    Vaccaro M; Moretti G; Guarneri F; Cannavò S; Magaudda L
    Eur J Dermatol; 2000 Aug; 10(6):436-8. PubMed ID: 10980463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
    Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
    Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin therapy for junctional epidermolysis bullosa.
    Rogers RB; Yancey KB; Allen BS; Guill MF
    Arch Dermatol; 1983 Nov; 119(11):925-6. PubMed ID: 6639114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dystrophic epidermolysis bullosa: surgical treatment of advanced hand deformities].
    Siepe P; Roessing C; Safi A
    Handchir Mikrochir Plast Chir; 2002 Sep; 34(5):307-13. PubMed ID: 12494382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
    Otte HG; Stieler W; Anton-Lamprecht I
    Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of esophageal stenosis in recessive dystrophic epidermolysis bullosa.
    Feurle GE; Weidauer H; Baldauf G; Schulte-Braucks T; Anton-Lamprecht I
    Gastroenterology; 1984 Dec; 87(6):1376-80. PubMed ID: 6436135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: report of three cases.
    Hasegawa T; Mizoguchi M; Haruna K; Mizuno Y; Muramatsu S; Suga Y; Ogawa H; Ikeda S
    J Dermatol; 2007 May; 34(5):328-32. PubMed ID: 17408442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment of Norwegian scabies with ivermectin in a patient with recessive dystrophic epidermolysis bullosa].
    Angelo C; Pedicelli C; Provini A; Annessi G; Zambruno G; Paradisi M
    Minerva Pediatr; 2004 Jun; 56(3):353-7. PubMed ID: 15252385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of elastase-type activity in blister fluids of recessive dystrophic epidermolysis bullosa.
    Francès C; Meimon G; Herson S; Robert L
    Clin Physiol Biochem; 1986; 4(6):350-4. PubMed ID: 3643827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
    Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
    Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a dermal skin substitute in the treatment of chronic wounds secondary to recessive dystrophic epidermolysis bullosa: a case series.
    Sibbald RG; Zuker R; Coutts P; Coelho S; Williamson D; Queen D
    Ostomy Wound Manage; 2005 Nov; 51(11):22-46. PubMed ID: 16319445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.